Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

v3.23.1
Stockholders’ Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jan. 26, 2023
May 31, 2020
Mar. 31, 2023
Dec. 31, 2022
Stockholders’ Equity (Details) [Line Items]        
Restricted stock units (in Shares) 11,332      
Received amount   $ 515,000    
Sale amount   $ 565,000    
Shares of common stock (in Shares)   135,527    
Price per share (in Dollars per share)   $ 3.8    
shares of common stock (in Shares)   169,409    
Exercise price (in Dollars per share)   $ 4    
Shares and warrants     $ 415,000  
Equity financing     125,000  
Unrecognized expense     $ 259,000 $ 222,000
Series A Convertible Preferred Stock [Member]        
Stockholders’ Equity (Details) [Line Items]        
Common shares (in Shares)     45,000,000  
Convertible preferred shares authorized (in Shares)     900,000  
Convertible preferred shares par value of per share (in Dollars per share)     $ 0.001